CORRECTION FROM SOURCE: VieCure Secures $45 Million Financing to Accelerate Adoption of First AI-Enabled Community Oncology Care Platform
Summary
Industry veteran Richard Daly named chairman of the board of directorsDENVER, CO / ACCESSWIRE / September 30, 2024 / VieCure Inc., pioneer of next-generation intelligence platforms that democratize community oncology care, today announced the completion of a $45 million financing led by Northpond Ventures and the appointment of industry veteran Richard Daly as chairman of the board of directors. This platform is the first AI-enabled community oncology care solution that combines clinical decision support and smart electronic medical records to help determine the right treatment path for every patient, every time. VieCures Halo Intelligence platform was designed to address the complexities of precision oncology data, offering industry-leading, AI-enabled capabilities that help oncologists identify the most effective treatments for each patients unique cancer profile.The complete VieCure platform includes an integrated ecosystem of tools, including an oncology information management system, AI engine, mobile patient and physician apps, a codified content library, integrated telehealth, and a modern analytics data environment. "Im looking forward to working with the team to help accelerate VieCures platform expansion across its national network of community cancer centers by supporting physicians and driving improved patient outcomes. "Michael Power, CEO of VieCure, said, "There are currently hundreds of precision oncology immunotherapies, targeted drugs, diagnostics, and biomarkers that lead to enormous complexities in delivering optimal patient care.